CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
80 hedge funds and large institutions have $92.4M invested in Concert Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
-7
Holders Change %
-8.05%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
34
Reduced
22
Closed
15
Calls
$2K
Puts
$1.2M
Net Calls
-$1.2M
Net Calls Change
-$1.49M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.09M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$1.01M |
| 3 |
Morgan Stanley
New York
|
+$921K |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$823K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$647K |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$19.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.69M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.33M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.32M |
| 5 |
Millennium Management
New York
|
-$918K |
